205 related articles for article (PubMed ID: 26954070)
21. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.
Smith TR; Liu-Mares W; Van Emburgh BO; Levine EA; Allen GO; Hill JW; Reis IM; Kresty LA; Pegram MD; Miller MS; Hu JJ
Carcinogenesis; 2011 Sep; 32(9):1354-60. PubMed ID: 21700777
[TBL] [Abstract][Full Text] [Related]
23. XRCC1 R399Q polymorphism and risk of normal tissue injury after radiotherapy in breast cancer patients.
Zhou Y; Zhou W; Liu Q; Fan Z; Yang Z; Tu Q; Li L; Liu H
Tumour Biol; 2014 Jan; 35(1):21-5. PubMed ID: 24292986
[TBL] [Abstract][Full Text] [Related]
24. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
Sigurdson AJ; Hauptmann M; Chatterjee N; Alexander BH; Doody MM; Rutter JL; Struewing JP
BMC Cancer; 2004 Mar; 4():9. PubMed ID: 15113441
[TBL] [Abstract][Full Text] [Related]
25. DNA-repair genetic polymorphisms and breast cancer risk.
Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
[TBL] [Abstract][Full Text] [Related]
26. Gene-to-gene interactions and the association of TP53, XRCC1, TNFα, HMMR, MDM2 and PALB2 with breast cancer in Kyrgyz females.
Isakova JT; Vinnikov D; Kipen VN; Talaibekova ET; Aldashev AA; Aldasheva NM; Makieva KB; Semetei Kyzy A; Bukuev NM; Tilekov EA; Shaimbetov BO; Kudaibergenova IO
Breast Cancer; 2020 Sep; 27(5):938-946. PubMed ID: 32297247
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk.
Shen J; Gammon MD; Terry MB; Wang L; Wang Q; Zhang F; Teitelbaum SL; Eng SM; Sagiv SK; Gaudet MM; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):336-42. PubMed ID: 15734955
[TBL] [Abstract][Full Text] [Related]
29. Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer.
Przybylowska-Sygut K; Stanczyk M; Kusinska R; Kordek R; Majsterek I
Clin Breast Cancer; 2013 Feb; 13(1):61-8. PubMed ID: 23103366
[TBL] [Abstract][Full Text] [Related]
30. RAD51 polymorphisms and breast cancer risk.
Hosseini M; Houshmand M; Ebrahimi A
Mol Biol Rep; 2013 Jan; 40(1):665-8. PubMed ID: 23065228
[TBL] [Abstract][Full Text] [Related]
31. XRCC1 and XRCC3 DNA repair gene polymorphisms in breast cancer women from the Lodz region of Poland.
Sobczuk A; Romanowicz-Makowska H; Fiks T; Baszczyński J; Smolarz B
Pol J Pathol; 2009; 60(2):76-80. PubMed ID: 19886181
[TBL] [Abstract][Full Text] [Related]
32. Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer.
Rybárová S; Vecanová J; Hodorová I; Mihalik J; Čižmáriková M; Mojžiš J; Solár P; Benický M; Adamkov M; Mirossay L
Med Sci Monit; 2011 Dec; 17(12):BR354-63. PubMed ID: 22129893
[TBL] [Abstract][Full Text] [Related]
33. Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients.
Deligezer U; Dalay N
Exp Mol Med; 2004 Dec; 36(6):572-5. PubMed ID: 15665590
[TBL] [Abstract][Full Text] [Related]
34. Single nucleotide polymorphisms of RAD51 G135C, XRCC2 Arg188His and XRCC3 Thr241Met homologous recombination repair genes and the risk of sporadic endometrial cancer in Polish women.
Romanowicz-Makowska H; Smolarz B; Połać I; Sporny S
J Obstet Gynaecol Res; 2012 Jun; 38(6):918-24. PubMed ID: 22487057
[TBL] [Abstract][Full Text] [Related]
35. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
Saadat M; Ansari-Lari M
Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
[TBL] [Abstract][Full Text] [Related]
36. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer.
Krupa R; Synowiec E; Pawlowska E; Morawiec Z; Sobczuk A; Zadrozny M; Wozniak K; Blasiak J
Exp Mol Pathol; 2009 Aug; 87(1):32-5. PubMed ID: 19426727
[TBL] [Abstract][Full Text] [Related]
38. DNA damage and repair in gastric cancer--a correlation with the hOGG1 and RAD51 genes polymorphisms.
Poplawski T; Arabski M; Kozirowska D; Blasinska-Morawiec M; Morawiec Z; Morawiec-Bajda A; Klupińska G; Jeziorski A; Chojnacki J; Blasiak J
Mutat Res; 2006 Oct; 601(1-2):83-91. PubMed ID: 16843501
[TBL] [Abstract][Full Text] [Related]
39. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
40. XRCC1 Arg399Gln and RAD51 5'UTR G135C polymorphisms and their outcome in tumor aggressiveness and survival of Portuguese breast cancer patients.
Costa S; Pinto D; Pereira D; Rodrigues H; Cameselle-Teijeiro J; Medeiros R; Schmitt F
Breast Cancer Res Treat; 2008 May; 109(1):183-5. PubMed ID: 17616806
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
